Target intelligence / Profile preview

GUSB pseudogene 13 (GUSBP13)

Target
GUSBP13
Molecular classification
Pseudogene
01

Overview

GUSB pseudogene 13 (GUSBP13) is classified as a processed pseudogene, meaning it originated from the retrotransposition of the mRNA transcript of the parental GUSB gene and is inserted at a different genomic locus[5][2]. Pseudogenes like GUSBP13 typically do not code for a functional protein due to the absence of regulatory elements or mutations in the coding sequence[2]. There are multiple pseudogenes related to the human GUSB locus, reflecting a history of retrotranspositional events[1][5]. Pseudogenes, in general, may sometimes participate in gene regulation (for instance, by acting as competing endogenous RNAs in some contexts), but no such function has been specifically ascribed to GUSBP13 in current databases or studies[2][5]. GUSB pseudogene 13 (GUSBP13) is a processed pseudogene, not a protein-coding gene, receptor, enzyme, or therapeutic target. It is correct as a gene symbol and full name and does not have known roles in disease, therapeutic targeting, or biomarker development[5][2].

Other names
GUSBP13

Beyond the preview

Go deeper on GUSB pseudogene 13 (GUSBP13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GUSB pseudogene 13 (GUSBP13).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call